Tech Company Financing Transactions

Ring Therapeutics Funding Round

On 3/9/2023, Ring Therapeutics received $86.5 million in Series C investment from Alexandria Venture Investments, Altitude Life Science Ventures and CJ Investment.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

620 Memorial Dr. 300
Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.ringtx.com

Email Address

[email protected]

Overview

Powering a New Era of Gene Therapy. We are developing Anellovectors, the first potentially redosable and targetable gene therapy platform, by harnessing the human commensal virome.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Tuyen Ong

        

Vice President

Simon Delagrave

        

VP - R & D

Roger Hajjar

        

Browse more venture capital transactions:

Prev: 3/9/2023: Eiwa venture capital transaction
Next: 3/9/2023: Gyroscope venture capital transaction

Share this article

Where The Data Comes From

We do our best to document funding rounds that are announced publicly. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary